SANGAMO THERAPEUTICS, INC. Debt Securities, Available-for-sale, Amortized Cost
SANGAMO THERAPEUTICS, INC. (SGMOQ) had Debt Securities, Available-for-sale, Amortized Cost of $115.85 million as of 2023-06-30, per its 10-Q filed 2023-08-08.
Discontinued › Notes › Credit Losses
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2023-08-08
- 2023-06-30: Debt Securities, Available-for-sale, Amortized Cost $115.85M.
- 2023-03-31: Debt Securities, Available-for-sale, Amortized Cost $163.04M.
- 2022-12-31: Debt Securities, Available-for-sale, Amortized Cost $207.92M.
- 2022-09-30: Debt Securities, Available-for-sale, Amortized Cost $257.09M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost |
|---|---|
| 2023-06-30 | $115.85M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $163.04M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $207.92M 10-Q · filed 2023-08-08 |
| 2022-09-30 | $257.09M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $247.51M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $281.43M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $286.14M 10-K · filed 2023-02-23 |
| 2021-09-30 | $342.08M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $408.92M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $506.45M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $560.58M 10-K · filed 2022-02-24 |
| 2020-09-30 | $434.85M 10-Q · filed 2020-11-04 |
| 2020-06-30 | $196.43M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $276.79M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $303.55M 10-K · filed 2021-02-24 |
| 2019-09-30 | $292.93M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $279.85M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $270.03M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $259.97M 10-K · filed 2020-02-28 |
| 2018-09-30 | $419.49M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $514.35M 10-Q · filed 2018-08-08 |
| 2017-12-31 | $194.75M 10-K · filed 2019-03-01 |